|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| This site is dedicated to Cindi McCain & Lou Grubb: Friends & Stroke Survivors....(ALLOW 1 MINUTE TO LOAD)....We search 100's of internet sites for daily news: New York Times, Washington Post, LA Times, Chicago Tribune, Harvard, Yale, UCLA, CNN, FOX, CBS, NBC, ABC, BBC, Journal of American Medical Assoc., New England Journal of Medicine, Mayo Clinic, Johns Hopkins Medicine, Cleveland Clinic, Memorial Sloan- Kettering, Reuters & 100's more...(WE DO NOT ACCEPT ADVERTISING) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Friday
"High-risk coronary heart disease patients achieve therapeutic goals effectively with rosuvastatin
Rosuvastatin 10 or 20 mg is an effective and safe therapeutic option for high-risk patients to achieve their lipid and apolipoprotein targets. According to a study from the United States, "National Cholesterol Education Program Adult Treatment Panel III guidelines for patients at a high risk of coronary heart disease set a low-density lipoprotein cholesterol (LDL-C) target of<100 mg/dL. This target can be difficult to attain with diet and current therapy." "In a 16-week multinational trial, 1993 high-risk patients were randomized to rosuvastatin 20 mg, atorvastatin 10 mg, atorvastatin 20 mg, simvastatin 20 mg, or simivastatin 40 mg for 8 ....... |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||